CABR

Caring Brands, Inc. (CABR) - 10-Q Summary for Period Ended September 30, 2025

Business Context and Reporting Period

Caring Brands, Inc. is a Nevada corporation operating as a wellness consumer products company, focusing on over-the-counter (OTC) and prescription-grade health products. The company recently separated from Safety Shot, Inc. via a reverse merger in September 2024 and is currently listed on NASDAQ. The filing covers the three and nine months ended September 30, 2025. The company is classified as an "emerging growth company" and a "smaller reporting company."

Key Financial Metrics

Note: Working Capital calculated as Current Assets ($45,991) minus Current Liabilities ($570,210).

Material Changes vs. Prior Period

• Revenue: The company generated nominal revenue ($740) in Q3 2025, whereas there was no revenue in the comparable period in 2024. The company remains in the product development and commercialization phase.
• Expenses: Selling, General, and Administrative (SG&A) expenses increased significantly to $999,923 in Q3 2025 from $428,906 in the comparable 2024 period. This increase is primarily driven by non-cash stock-based compensation ($1,007,000 for the nine months) issued for consulting, investor relations, and advisory services.
• Debt: The company incurred new debt in 2025, including a $200,000 convertible promissory note facility with Greentree Financial Group (of which $120,000 was drawn as of Sept 30) and related party loans totaling $129,405. There was no debt as of December 31, 2024.
• Liquidity: Cash balances decreased from $468,998 at year-end 2024 to $16,123 as of September 30, 2025, due to operating losses and working capital needs.

Guidance, Outlook, and Risks

Outlook and Capital Needs: Management states that current cash levels are insufficient to support business plans. The company is in the process of completing a public offering expected to raise approximately $4.0 million to fund operations for the next twelve months. Without this capital, the company may need to rely on additional debt or equity financing, which may not be available on favorable terms.

Going Concern: The financial statements include a "Going Concern" warning. Auditors have raised substantial doubt about the company's ability to continue as a going concern due to recurring losses and limited operating history.

Key Risks:

• Internal Controls: Management identified a material weakness in internal controls over financial reporting, noting that accounting transactions were not initially recorded correctly.
• Separation Risks: Risks related to the recent separation from Safety Shot, Inc., including potential conflicts of interest with directors holding positions in both entities.
• Intellectual Property: Significant reliance on a license agreement with NovoDX for the GoldNTM Ebola Rapid Diagnostic Test, which represents a major intangible asset ($2.625 million net).

Investor Verification Checklist

• Capital Raise Status: Verify the status and expected closing date of the $4.0 million public offering mentioned in the MD&A.
• Debt Covenants: Review the terms of the Greentree Financial Group convertible note, specifically the conversion price ($2.00 or latest sale price) and the impact of the 10% original issue discount.
• Related Party Transactions: Scrutinize the $129,405 in related party loans (including loans from the CEO and Chairman) and the $54,405 owed to Safety Shot, Inc.
• Stock-Based Compensation: Confirm the valuation methodology for the 625,000 shares issued for services in the nine-month period, which significantly impacted the net loss.
• Internal Control Remediation: Assess the timeline and plan for remedying the identified material weakness in financial reporting controls.